Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 1, 2003AIDS

Failures of 1 week on, 1 week off antiretroviral therapies in a randomized trial

View Full Paper
Ask AI
Bookmark
Share

Authors

JAJintanat AnanworanichHenry M. Jackson FoundationRNReto NüeschSpital LinthMBMichelle Le BrazUniversity Hospital of Geneva

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Ananworanich et al. (2003) studied this question.

synapsesocial.com/papers/6a954773aec9be1889e3cef5https://doi.org/10.1097/00002030-200310170-00001
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Short-cycle structured intermittent treatment of chronic HIV infection with highly active antiretroviral therapy: Effects on virologic, immunologic, and toxicity parameters2001 · 156 citations
  2. 2Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection2002 · 213 citations
  3. 3A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less1997 · 2,684 citations
  4. 4Drug Resistance Mutations in HIV-1-Infected Subjects during Protease Inhibitor-Containing Highly Active Antiretroviral Therapy with Nelfinavir or Indinavir2001 · 20 citations